Reduced Risk of Cancer in Low-risk Monoclonal Gammopathy
Low-risk monoclonal gammopathy is characterized by a lower likelihood of developing cancerous conditions compared to other forms of gammopathy. Studies have shown that individuals with this condition have only a two percent chance of their condition progressing to multiple myeloma or a related disorder within the next two decades. Several factors contribute to this reduced risk, including the presence of IgG type M-protein in the blood, a low M-protein level of less than 15g/L, and a normal free light chain ratio.
Understanding High-risk Monoclonal Gammopathy
High-risk monoclonal gammopathy refers to a condition in which individuals have specific characteristics that indicate a higher likelihood of developing multiple myeloma or a related disorder in the future. These characteristics include an M-protein level of more than 15 g/L, presence of IgM or IgA type M-protein in the blood, and an abnormal free light chain ratio.
If all three of these features are present in an individual, there is a 58% chance of them developing multiple myeloma or a related disorder within the next 20 years. However, if only one or two of these features are present, the risk is significantly lower.